Blazing Star Merger Sub completes Walgreens debt tender offer
WINSFORD, UK - Advanced Medical (TASE:BLWV) Solutions Group plc (AIM:AMS (VIE:AMS2)), a leader in tissue-healing technologies, has announced a rescheduling of its Annual General Meeting (AGM) to June 30, 2025. The change comes after an unexpected alteration in the audit team at Deloitte LLP, which has delayed the signing of the Annual Report and Accounts.
In connection with this scheduling update, the company has also modified the record date for its proposed final dividend. Shareholders on the register at the close of business on June 20, 2025, will be eligible for the dividend, subject to shareholder approval at the AGM. This dividend, set at 1.83p per share, is slated for distribution on July 17, 2025.
The initial announcement of the company’s FY24 Unaudited Preliminary Results was made on March 19, 2025, under RNS 2726B. This recent adjustment to the dividend record date aligns with the new AGM schedule, ensuring compliance with corporate governance requirements and providing clarity to shareholders.
Advanced Medical Solutions Group is recognized for its comprehensive portfolio of surgical products, including tissue adhesives, sutures, haemostats, and fixation devices, which are marketed under various brands such as LiquiBand®, RESORBA®, and Seal-G®. The company also offers wound care dressings through its ActivHeal® brand, in addition to products available under white label.
With a global presence, AMS products are manufactured across several countries and sold through a combination of multinational and regional partners, as well as direct sales forces in select markets. The Group is committed to research and development, with innovation hubs located in the UK, Ireland, Germany, France, and Israel.
This information is based on a press release statement issued by Advanced Medical Solutions Group plc.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.